SEC Form D · filed June 29, 2023
Centrexion Therapeutics Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
James N. Campbell, M.D · Boston, MAExec · DirectorJ.C. J. Lopez, M.D · Boston, MADirectorColin J. Hill · Boston, MADirectorMichael J. Ward · Boston, MAExecRandall M. Stevens · Boston, MAExecJoseph R. Swedish · Boston, MADirectorJeffrey B. Kindler · Boston, MAExec · DirectorSol J. Barer, Ph.D · Boston, MADirectorShawn R. Tomasello · Boston, MADirectorIain R. Macleod · LONDON, United KingdomDirectorDeryk I. King · LONDON, United KingdomDirectorPaul R. Malan · LONDON, United KingdomExec · DirectorGiovanni J. Maso · New York, NYExecDaniel M. Agostino · LONDON, United KingdomDirectorFarooq Abbasi · New York, NYDirectorChuck Templeton · CHICAGO, ILExec · DirectorAlcides Ferreira · Dayton, OHExecHealthTronics Stone Solutions LLC · Round Rock, TXDirectorJean-Francois Clavier · San Francisco, CAExec · DirectorAndrew Mcloughlin · San Francisco, CADirectorHershel Mehta · La Habra, CADirectorTomaz Strgar · Sentjernej, 2AExec · DirectorJason Long · La Jolla, CADirectorHongliang Zhou · Denver, CODirectorBrandon M. Levitan · CHICAGO, ILExecGeorge Athanasiadis · San Juan, Puerto RicoDirectorAllen Kurt · VANCOUVER, British Columbia, CanadaExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗